“The Temporal-Epidemiological Standard” – AMS v Birthistle [2025] IEHC 331

Introduction

AMS v Birthistle is the High Court of Ireland’s first reported decision dealing with failure to diagnose visceral leishmaniasis (VL) in an HIV-positive patient. Ms Justice Egan was asked to decide whether St James’s Hospital (SJH) breached the Dunne-Morrissey standard when five consultants did not consider VL during a 42-day admission in 2014.

The Court was required to balance:

  • the clinicians’ admitted ignorance (or partial knowledge) of the epidemiological link between HIV and VL in Spanish patients,
  • the competing, initially credible diagnosis of HLH triggered by HIV/HHV-8, and
  • the evolving clinical picture which eventually undermined that working theory.

The outcome refines the law on diagnostic negligence by introducing what this commentary terms the Temporal-Epidemiological Standard – a duty to bring an epidemiological association to bear once the initial working diagnosis ceases to provide a credible explanation of the patient’s course. The principle recognises that knowledge alone does not oblige a physician to test immediately for every rare condition, but that the duty crystallises when events “trigger” the association into practical relevance.

Summary of the Judgment

  1. Standard of Care: The Court re-affirmed the Dunne principles, as restated in Morrissey v HSE, for diagnosis cases. The critical question was whether the failure was one “no reasonable clinician” would make.
  2. Knowledge Requirement: By 2014 an infectious-disease (ID) specialist treating HIV patients should have known of the HIV/VL association in Spain.
  3. But Not an Automatic Duty: That knowledge did not oblige doctors to test for VL on admission when a credible alternative explanation (HLH driven by HIV & HHV-8) existed.
  4. Trigger Point: From 10-14 March 2014—when HHV-8 viral load became negative, chemotherapy had had time to work, yet the patient deteriorated—the epidemiological knowledge should have moved VL into the differential. Failure to do so breached the standard.
  5. Causation & Damages: Empirical AmBisome should have started by mid-March; had it done so the plaintiff would probably have recovered three weeks earlier. General damages (no future loss) were assessed at €26,000.

Analysis

1. Precedents Cited

  • Dunne v National Maternity Hospital [1989] IR 91 – foundational six-step test for medical negligence.
  • Morrissey v HSE [2020] IESC 6 – clarified that courts must identify the standard of approach of the profession itself.
  • Langley v Campbell (1975) – GP’s duty to rethink diagnosis when a traveller’s fever persisted. Used by plaintiff but distinguished by the Court.
  • O’Driscoll v Hurley [2015] IECA 158 & Ewing [1998] – consulted for guidance on quantum rather than liability.

The Court treated Dunne principle 1 as decisive; principles 2-4 (divergent practice, honest difference, inherent defects) were not engaged because there were no “two schools of thought” on diagnosing VL.

2. Legal Reasoning

(a) Constructing the Standard of Approach

“It is the standards of the profession itself, as demonstrated by the evidence, that impose the standard required.” — Egan J, para 41

The judge built the standard in two layers:

  1. Core knowledge – an Irish HIV specialist in 2014 must know the HIV/VL link for Spanish patients.
  2. Contextual application – whether, given the evolving clinical facts, a reasonable doctor would act on that knowledge.

(b) The Epidemiological Trigger

The Court coined no label, but its reasoning establishes that:

  • Epidemiological facts (here: nationality, HIV status) are always relevant,
  • but they gain operative force only after “the common becomes significantly less likely”.
  • At that juncture the duty flips from passive knowledge to active inquiry; failing to add VL to the differential is negligent.

(c) Massive Splenomegaly Argument Rejected

Plaintiff experts insisted the 22 cm spleen was a “barn-door” sign of VL. The judge noted that neither expert had flagged this in their reports, saw the reliance as “confirmation bias”, and held that HLH itself commonly produces splenomegaly; therefore the size did not compel earlier VL testing.

(d) Causation Findings

  • No negligence pre-10 March (chemotherapy had to be tried).
  • Negligence thereafter delayed AmBisome by ≈3 weeks; earlier start would have shortened hospital stay and symptoms by the same period.

(e) Damages Calculation

Using Book of Quantum analogies (food-poisoning admissions) the Court pegged a full-liability figure at €40-42.5k and discounted to €26k to reflect the three-week “excess” suffering.

3. Impact of the Decision

  • Temporal Duty Articulated – Courts will now scrutinise when an epidemiological association should crystallise into a diagnostic obligation, not merely whether doctors knew the association.
  • Guidance for Multicultural Clinics – Teaching hospitals managing international cohorts must ensure staff training covers major epidemiological links, and must document re-evaluation when initial treatments stall.
  • Limited Scope – The judgment does not impose a blanket duty to test every rare infection on admission; it balances clinical practicality with patient safety.
  • Expert Evidence Caution – Emphasises consistency between written reports and oral testimony; courts may discount “late-breaking” opinions (here, the splenomegaly point).
  • Modest Damages Trend Continues – Reiterates that short-term exacerbation without long-term sequelae attracts restrained awards post-Guidelines.

Complex Concepts Simplified

  • Visceral Leishmaniasis (VL): A parasitic disease transmitted by sandflies; fatal if untreated but curable with AmBisome (liposomal amphotericin B).
  • Hemophagocytic Lymphohistiocytosis (HLH): An aggressive, often lethal immune-system over-activation. It can be “primary” (genetic) or “secondary” (triggered by infection, malignancy, etc.).
  • Empirical Therapy: Treating before definitive lab confirmation when suspicion is high and delay would be dangerous.
  • Epidemiological Association: A statistically observed link (e.g., HIV patients in Spain have a higher VL prevalence). It is a signal, not a diagnosis.
  • Massive Splenomegaly: Spleen >8 cm below left costal margin or >1 kg. It narrows but does not dictate the differential diagnosis.

Conclusion

AMS v Birthistle refines Irish medical-negligence jurisprudence by injecting a temporal dimension into diagnostic duties: clinicians must carry relevant epidemiological knowledge in their toolkit, but they breach their duty only when ongoing clinical data should have triggered the application of that knowledge and did not.

Practically, hospitals must:

  1. educate clinicians on key geography-disease links affecting their patient demographics,
  2. document periodic re-evaluation of differential diagnoses, and
  3. institute protocols for early empirical therapy once “considerable suspicion” arises.

The judgment harmonises epidemiological vigilance with realistic clinical workflow, protecting patients without imposing impossible diagnostic omniscience.